Artifex
News: In a joint effort with the University Hospital in Basel and the Medical University in Vienna, ArtiFex secured €350k in their first funding…
PoroUS securing a first round investment
News: In cooperation with the Charité University in Berlin, PoroUS has made big progress executing it’s strategy to ultimately avoid osteoporosis in patients by…
Concord generated its first sales in Germany
News: Concord generated its first sales in Germany. The University Hospital Dresden became the first hospital in Germany to perform the Concord Birth Flow. On…
SuperSeton – because life is more convenient without knots
News: Despite COVID measures across Europe, heavily affecting fistula treatmen through postponement or cancellation, SuperSeton had its best quarter ever. Our expanding network of…
NICO.LAB reaches major milestone
News: One of the first ventures NLC built (in 2015) has grown wings to fly. Recently NICO.LAB announced a major milestone: the closing of a…
Next generation financing instruments for early stage biotech ventures in Europe
Friday April 16th, 10:30 – 11:00, live from the studio at the Innovation for Health event, Koen Verhoef, Head of Knowledge Transfer & Contracting…
Press Release: NLC closes second funding round of Stepping Stone Fund to finance 40 new promising HealthTech ventures
Amsterdam, Thursday 25 March 2021 – We are very pleased to announce that we’ve closed the second funding round of our Stepping Stone Fund. With…
A lot to celebrate at PEP Health with Meghan Leaver
Recently there’s been a lot to celebrate at PEP Health. The Department of International Trade listed PEP on its ’25 to watch’ list and…
Five recommendations for optimal venture growth in your first six months!
With innovation becoming more and more important in today’s business world; the amount of aspiring entrepreneurs is growing and growing. We at NLC –…